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Abstract
Coronavirus disease-19 (COVID-19) resulted in widespread concern in global public health and has a bad prognosis 
despite drug therapy. The patient was an 11-year-old girl referred to a children hospital with a dry cough, fever, and 
headache symptoms, without comorbidity. She was hospitalized following the results of high-resolution computed 
tomography (HRCT). The patient was treated with ceftriaxone 1 g every 12 h and the oseltamivir capsule 45 mg 
every 12 h and azithromycin 250 mg tablet once daily and 200 mg hydroxychloroquine tablet every 12 h for a total 
of 5 days. After 5 days, the patient had suitable chest status and then was discharged. Azithromycin for 5 days 
and hydroxychloroquine for 10 days were prescribed for the patient to take at home. The patient’s polymerase 
chain reaction (PCR) was negative at baseline through the nasopharyngeal swap, but HRCT of the patient’s was 
completely consistent with COVID-19 accompanied by consolidation and ground-glass opacity in the left lower and 
right upper lobes. The numerous technical errors in taking the nasopharyngeal swap were the main reasons for the 
negative PCR. The main lesson from this case report is the high sensitivity and specificity of HRCT compared to 
the PCR.
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Introduction
Coronavirus disease-19 (COVID-19) is caused 
by severe acute respiratory syndrome coronavirus 2 
(SARS-COV2) and is a causative agent of a potentially 
fatal disease that has caused widespread concern 
in the global public health. Coronavirus is one of 
the largest pathogens that mainly target the human 
respiratory tract, which has a bad prognosis despite 
drug therapy [1], [2].
Moreover, SARS-COV2 results in multi-
organ failure, such as renal and liver failure [3], [4]. 
Regarding prevalence, these patients were associated 
with a wholesale market for seafood and wet animals 
in Wuhan, Hubei Province, China [5], [6]. Preliminary 
reports predicted the launch of a potential coronavirus 
epidemic with a basic reproduction number (R0) varying 
from 2.24 to 3.58 [7]. A study by Wang et al. showed 
that the ratio of male-to-female mortality was 3.25 to 1, 
the median age of death was 75 years, the median time 
from the first symptoms to death was 14 days, and the 
median time from the initial symptoms to death above 
70 years was shorter (11.5 days) than in people under 
70 years of age (20 days). These findings suggest that 
the disease may progress more rapidly in adults than in 
young people [8].
Li et al. reported the mean age of 59 years 
for coronavirus-positive patients, of which 56% were 
men, the mean incubation period was 2.5 days, and 
almost half of the adult patients were 60 years and 
older [9]. The treatment of coronavirus in most cases 
is unnecessary because most patients have mild or 
moderate symptoms. However, it may be necessary to 
identify an etiological factor in epidemiological studies, 
especially during epidemic outbreaks. Since the novel 
coronavirus-2019 has not been found in humans before, 
no specific vaccine or treatment has been provided. In 
the current state of emergency, the number of cases is 
rapidly increasing. Therefore, it is important to diagnose 
all suspected cases as soon as possible and to remove 
them quickly to cutoff the source of the infection. New 
diagnostic solutions, including reverse transcription 
PCR and microscopic-based measurements, may be 
effective in monitoring epidemiological measures, along 
with preventive measures [10]. Coronavirus Novin-
2019 nucleic acids can be detected in samples such 
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as nasopharyngeal swabs, sputum, lower respiratory 
tract secretions, blood, and feces [11], [12]. Therefore, 
we present a case report of different radiologic findings 
apart from PCR results.
Case Presentation
The patient was an 11-year-old girl referred to a 
children hospital with a dry cough, fever, and headache 
symptoms, without comorbidity, and with a history of 
adenoidectomy and ventilation tube implantation in 
both ears 9 months ago. She was hospitalized following 
the results of high-resolution computed tomography 
(HRCT) and imaging due to the aggravation of 
coughs. At the time of admission, height, weight, Spo2, 
respiratory rate, heart rate, and axillary temperature 
were 145 cm, 24 kg, 97% (on room air), 17 breaths/
min, 97 beats/min, and 38.5°C, respectively. Laboratory 
results were as following:
C-reaction protein = +1, white blood cell (WBC): 
5200/mm3, lymph: 17%, neut: 75%, platelet) = 216,000, 
hemoglobin: 12.5 mg/dl, aspartate aminotransferase 
(AST) = 30 Iu/l, alanine transaminase (ALT) = 35 IU/l, 
alkaline phosphatase = 135 IU/l, prothrombin time = 13 s, 
partial thromboplastin time = 45 s, international 
normalized ratio = 1.1, serum calcium (Ca) = 8.8 mg/dl, 
25 (oH) Vitamin D level = 52 ng/ml, blood urea nitrogen = 
8 mg/dl, creatinine (Cr) = 0.6 mg/dl, erythrocyte 
sedimentation rate = 30 mm/hand, and lactate 
dehydrogenase = 461 IU/L.
The patient was treated with ceftriaxone 1 g 
every 12 h and the oseltamivir capsule 45 mg every 
12 h and azithromycin 250 mg tablet once daily and 
200 mg hydroxychloroquine tablet every 12 h for a 
total of 5 days. After 5 days, the patient had suitable 
chest status and then was discharged. Azithromycin 
for 5 days and hydroxychloroquine for 10 days were 
prescribed for the patient to take at home.
The patient’s PCR was negative at baseline 
through the nasopharyngeal swap. HRCT of the 
patient’s, which was reported by two radiologists, was 
completely consistent with COVID-19.
In Iran, there is no kit to detect coronavirus 
antibodies (IgM and IgG). The patient had previously 
been visited by an otorhinolaryngologist and had no 
upper airway problems and most of the symptoms were 
in the lower airway.
Due to the absence of respiratory distress and 
Spo2 above 94%, blood gas was not taken from the 
patient. Due to the good general condition, the PCR 
test was not taken after discharge and was quarantined 
for only 2 weeks. Due to a large number of false 
negatives in the nasopharyngeal swab sample and the 
failure to obtain the correct sample or CT scan based 
on COVID19, which was reported by two radiologists, 
the PCR test and CT were not performed again.
Figure 1 represents a consolidation and 
ground-glass opacity (GGO) in the left lower lobe. 
Figure 2 represents consolidation and GGO in the right 
upper lobe. Figure 3 shows no significant findings in the 
chest-X ray.
Figure 1: Consolidation and ground-glass opacity in the left lower 
lobe in high-resolution computed tomography
Figure 2: Consolidation and ground-glass opacity in the right upper 
lobe in high-resolution computed tomography
Discussion
Guan et al. reported 1099 cases of the novel 
2019 coronavirus infection. They found that fever (78.9%) 
and cough (67.7%) were the most common symptoms. 
Abnormalities in CT images of the chest were observed in 
96% of patients infected with the novel coronavirus-2019, 
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and lymphocytopenia was recorded in 82.1% of them 
[9]. Our case was the same indicating that dry cough 
and fever can be common in the children too. WBC of 
5200/mm3, lymph of 17%, and neut of 75% showed 
lymphocytopenia of our case. In some studies, it has 
been reported that chest X-rays do not have enough 
sensitivity and specificity; thus, CT scans should be done 
like our case [13], [14], [15]. In the present case, chest 
X-ray was normal and could not detect COVID-19; then, 
we had no choice to check the CT scan of the patients. 
In the assessment of HRCT, we found that the lung had 
consolidation and GGO in the right upper and left lower 
lobes. In spite of the negative result of PCR, the radiologic 
findings approved COVID-19. Therefore, clinicians should 
check CT to approve the definite diagnosis of COVID-19. 
Hence, the majority of patients infected with the novel 
coronavirus-2019 can be diagnosed by CT. The fact that 
“children are not very susceptible” may jeopardize their 
health. Children should be prevented to have a close 
contact with the epidemic area and people [16], [17].
Huang et al. found that 98% of patients with 
COVID-19 had a fever. They reported that 76% of 
patients had a cough with dyspnea. Furthermore, a 
small number of patients had expectoration sputum. 
Laboratory tests showed that 25% of infected patients 
had leukopenia and 64% had lymphocytopenia. AST 
levels were elevated in 37% of patients. Abnormalities 
in chest CT images were observed in 100% of patients. 
GGO and consolidation areas were found in 37% of 
the lungs on both sides of infected patients [18]. The 
findings of CT of the present case were consistent 
with the study of Huang et al. In the present case, liver 
function tests were normal (AST=30 Iu/l, ALT= 35IU/l, 
and ALO=135 IU/l), in such a way that was inconsistent 
with the study by Huang et al. [18]. 
Conclusion
The number and severity of pulmonary 
involvement in children are lower than adults based 
on Chinese and the previous articles. In our case, the 
severity of the symptoms was mild, and the numerous 
technical errors in taking the nasopharyngeal swap 
were the main reasons for the negative PCR, but HRCT 
apparently showed COVID-19. The main lesson from 
this case report is the high sensitivity and specificity of 
HRCT compared to the PCR.
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